A study on acceptance of covid19 vaccinationBooster dose among general public in dakshina kannada

Reference

1. Achrekar GC, Batra K, Urankar Y, Batra R, Iqbal N, Choudhury SA, et al. Assessing covid-19 booster hesitancy and its correlates: An early evidence from India [Internet]. Multidisciplinary Digital Publishing Institute; 2022 [cited 2023 Nov 9]. Available from: https://www.mdpi.com/2076-393X/10/7/1048
2. Watson, Oliver J. "Global impact of the first year of COVID-19 vaccination: a mathematical modelling study". The Lancet Infectious Diseases. 23 June 2022 ;22 (9): 1293–1302
3. Vaccine efficacy, effectiveness and protection [Internet]. World Health Organization; [cited 2023 Nov 10]. Available from: https://www.who.int/news-room/feature-stories/detail/vaccine-efficacy-effectiveness-and-protection
4. Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spect et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2020; 384: 403–16
5. Voysey, M. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet (London, England).2020; 397: 881–891.
6. Jackson LA, Anderson EJ, Rouphael NG. An mRNA vaccine against SARS-CoV-2— preliminary report. N Engl J Med. 2020; 383:1920–31
7. Gür E. Vaccine hesitancy—vaccine refusal. Turk Pediatr Ars. 2019; 54:1–2
8. Zhu F.-C., Li Y.-H., Guan X.-H., Hou L.-H., Wang W.-J., Li J.-X., Wu S.-P et al., tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet. 2020;395(10240):1845–1854
9. Sharp G, Fraser A, Sawyer G, et al. The covid-19 pandemic and the menstrual cycle: Research gaps and opportunities. OSF Preprints, 8 June. 2021
10. Chagla, Z.; Pai, M. COVID-19 boosters in rich nations will delay vaccines for all. Nat. Med. 2021, 27, 1659–1660
11. Heywood AE, Macintyre CR. 2020 Elimination of COVID-19: what would it look like and is it possible? Lancet Infect. Dis. 20, 1005–1007.
12.  Yang R, Penders B, Horstman K. Addressing Vaccine Hesitancy in China: A Scoping Review of Chinese Scholarship. Vaccines. 2019;8(1)